Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirish M Gadgeel

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Advances in Experimental Medicine and Biology|December 26, 2015
Personalized Therapy of Non-small Cell Lung Cancer (NSCLC)Shirish M Gadgeel
Current Oncology Reports|June 18, 2013
New targets in non-small cell lung cancerShirish M Gadgeel
The Lancet. Oncology|November 15, 2016
Drug selection for anaplastic lymphoma kinase-positive non-small-cell lung cancerShirish M Gadgeel
Lung Cancer (Amsterdam, Netherlands)|April 3, 2017
Optimal front-line ALK (anaplastic lymphoma kinase) directed therapyShirish M Gadgeel
Clinical Lung Cancer|June 28, 2006
Smoking history: tumor biology and clinical pharmacokinetic implications in patients with lung cancerShirish M Gadgeel
Current Treatment Options in Oncology|September 12, 2018
Targeted Therapy and Immune Therapy for Small Cell Lung CancerShirish M Gadgeel
Current Oncology Reports|April 12, 2011
The optimal chemotherapy for stage III non-small cell lung cancer patientsShirish M Gadgeel
Current Treatment Options in Oncology|May 24, 2017
Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung CancerShirish M Gadgeel
Clinical Lung Cancer|March 18, 2009
Targeted therapy in lung cancer: the good, the bad, and the uglyShirish M Gadgeel
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Role of Chemotherapy and Targeted Therapy in Early-Stage Non-Small Cell Lung CancerShirish M Gadgeel
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Advances in Experimental Medicine and Biology|December 26, 2015
Personalized Therapy of Non-small Cell Lung Cancer (NSCLC)Shirish M Gadgeel
Current Oncology Reports|June 18, 2013
New targets in non-small cell lung cancerShirish M Gadgeel
The Lancet. Oncology|November 15, 2016
Drug selection for anaplastic lymphoma kinase-positive non-small-cell lung cancerShirish M Gadgeel
Lung Cancer (Amsterdam, Netherlands)|April 3, 2017
Optimal front-line ALK (anaplastic lymphoma kinase) directed therapyShirish M Gadgeel
Clinical Lung Cancer|June 28, 2006
Smoking history: tumor biology and clinical pharmacokinetic implications in patients with lung cancerShirish M Gadgeel
Current Treatment Options in Oncology|September 12, 2018
Targeted Therapy and Immune Therapy for Small Cell Lung CancerShirish M Gadgeel
Current Oncology Reports|April 12, 2011
The optimal chemotherapy for stage III non-small cell lung cancer patientsShirish M Gadgeel
Current Treatment Options in Oncology|May 24, 2017
Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung CancerShirish M Gadgeel
Clinical Lung Cancer|March 18, 2009
Targeted therapy in lung cancer: the good, the bad, and the uglyShirish M Gadgeel
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Role of Chemotherapy and Targeted Therapy in Early-Stage Non-Small Cell Lung CancerShirish M Gadgeel
Pageof 16